TechConnect #techconnect keeps getting better every year! Anaheim was a great location, with a good mix of entrepreneurs and investors! Looking forward to the next one in Boston in May 2019. I chaired a very engaging panel of experts who elaborated on the biggest problem facing the industrial production of uniform nanoparticles. I showcased Notre Dame’s expanding Nanoparticles synthesis capabilities. Prof. Leevy talked about the challenges of being an entrepreneur in an academic setting and how Notre Dame’s IDEA center #IDEAcenter is making that process easier. Dr. Andrew Wang, the co-founder of Ocean Nanotech and Alpha BioBeads, talked about the current challenges of commercially synthesizing nanomaterials. Dr. Wei Wang or Saudi Aramco Research Center further expounded on the need to translate nanotechnology from a working concept in the lab to a fully working field instrument in challenging environments such as offshore oil wells. Finally, Dr. Parlak who founded ‘Qatch diagnostics technologies’ talked about the joys, pains and unique satisfaction of running a startup.
May 14
TechConnect 2018 an SBIR/STTR Haven
Categories:
Berthiaume Institute for Precision Health, Biomedical Imaging, Conference abstracts, SBIR/STTR
by Prakash
This post has no tag
Recent Posts
- Phage-Mimicking Antibacterial Nanoparticles Tackle Group A Streptococcal Infections In Vivo January 29, 2024
- 2nd Annual Berthiaume Institute for Precision Health’s Advisory Board Meeting October 30, 2023
- 1st Place Poster at the Military Health Sciences Research Symposium 2023 (Aug 14-17, Kissimmee, FL) August 14, 2023
- Congratulations to Ms. Johanna Olesk on Defending her MS (Bioengineering) ’23 Thesis July 7, 2023
- Translational Science to Impact Public Health was our Goal at Techconnect 2023 June 17, 2023
Archives
Categories
NIH Funding Opportunities
- Notice of Correction to PAR-23-199 "ClinGen Curation Expert Panels (U24 Clinical Trials not Allowed)" June 28, 2024Notice NOT-HD-24-025 from the NIH Guide for Grants and Contracts
- Notice of Early Expiration and Reissuance of NOT-HL-22-039 "Notice of Special Interest (NOSI): Administrative Supplements to Support Programs for Inclusion and Diversity Among Individuals Engaged in Health-Related Research (PRIDE) Small Research Projects" June 28, 2024Notice NOT-HL-24-020 from the NIH Guide for Grants and Contracts
- NIH HEAL Initiative PainCare Clinician Training Program (PCTP): Mentored Patient-Oriented Research Career Development award (K23 - Clinical Trial Required) June 28, 2024Funding Opportunity PAR-24-220 from the NIH Guide for Grants and Contracts. The purpose of this NIH HEAL Initiative PAINCare Clinician Training Program (PCTP): Mentored Patient-Oriented Research Career Development award (K23) (Clinical Trial Required) is to support a cohort of new and well-trained, independent investigators. The program will provide independent NIH research support during the early-career […]
- NIH HEAL Initiative PainCare Clinician Training Program (PCTP): Mentored Clinical Scientist Development Awards (K08 - Clinical Trials Not Allowed) June 28, 2024Funding Opportunity PAR-24-219 from the NIH Guide for Grants and Contracts. The purpose of this NIH HEAL Initiative PAINCare Clinician Training Program: PCTP): Mentored Clinical Scientist Development Awards (K08) (Clinical Trials Not Allowed)is to support a cohort of new and well-trained, independent investigators. The program will provide independent NIH research support during the early-career phase […]
- NIH HEAL Initiative PainCare Clinician Training Program (PCTP): Mentored Clinical Scientist Development Awards (K08 - Basic Experimental Studies with Humans (BESH) Required) June 28, 2024Funding Opportunity PAR-24-218 from the NIH Guide for Grants and Contracts. The purpose of this NIH HEAL Initiative PAINCare Clinician Training Program(PCTP): Mentored Clinical Scientist Development Awards (K08) (BESH)is to support a cohort of new and well-trained, independent investigators. The program will provide independent NIH research support during the early-career phase to help awardeesestablish independent […]
- Notice of Special Interest (NOSI): Epigenetic Modulation of HBV cccDNA and integrated HBV DNA (iDNA): Implications for Epigenetic Treatment Strategies Against HBV in HIV/HBV Co-Infection June 28, 2024Notice NOT-AI-24-050 from the NIH Guide for Grants and Contracts
- Notice of Intent to Publish a Funding Opportunity Announcement for Scaling-up and Maintaining Evidence-based Interventions to Maximize Impact on Cancer (SUMMIT) - Tobacco Use Treatment for Cancer Survivors (UG3/UH3 Clinical Trial Required) June 27, 2024Notice NOT-CA-24-076 from the NIH Guide for Grants and Contracts
- NIMH Research Education Mentoring Program for HIV Researchers (R25 Clinical Trial Not Allowed) June 27, 2024Funding Opportunity PAR-24-233 from the NIH Guide for Grants and Contracts. The NIH Research Education Program (R25) supports research education activities in the mission areas of the NIH. The over-arching goal of this National Institute of Mental Health (NIMH) R25 program is to support educational activities that complement and/or enhance the training of a workforce […]
- NIH HEAL Initiative PainCare Clinician Training Program (PCTP): Mentored Clinical Scientist Development Awards (K08 - Clinical Trials Required) June 27, 2024Funding Opportunity PAR-24-217 from the NIH Guide for Grants and Contracts. The purpose of this NIH HEAL Initiative PAIN Care Clinician Training Program: PCTP): Mentored Clinical Scientist Development Awards (K08) (Clinical Trials Required) is to support a cohort of new and well-trained, independent investigators. The program will provide independent NIH research support during the early-career […]
- Notice of Special Interest (NOSI): Discovery and Development of Oral Small-molecule Direct-acting Antivirals Targeting Viruses of Pandemic Potential June 27, 2024Notice NOT-AI-24-053 from the NIH Guide for Grants and Contracts
Recent Comments